Scholarly Works - Conferences
Conference
Arthritis Rheumatol
·
July 2018
OBJECTIVE: To evaluate circulating cytokine profiles in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV), classified by antineutrophil cytoplasmic antibody (ANCA) specificity (proteinase 3 ANCA [PR3-ANCA] versus myeloperoxidase ...
Full text
Link to item
Cite
Conference
Annals of the Rheumatic Diseases
·
January 1, 2002
Infliximab is a chimeric anti-tumour necrosis factor α (TNFα) monoclonal antibody with high affinity and binding specificity for human TNFα. Results from several well designed, controlled clinical trials show repeated infusions of infliximab with concomita ...
Full text
Cite
